Psychedelics Today

In today's Solidarity Fridays episode, Joe and Kyle discuss recent items in the news. They cover a new LSD microdose trial to study the effects of 5, 10, or 20 µg on acute pain, seeing how long participants could hold their hands in 37.4° F water. Led by researchers from Maastricht University with help from the Beckley Foundation, this is the first study of its kind since Eric Kast first studied the effects of LSD on acute pain in the 1960s, and could help lead to LSD being prescribed for acute pain over the more standard and very addictive and dangerous opioids. This leads towards the topic of pain in general and our relationship with it- can we figure out how to have pain not affect us the same way by not giving it the same attention we're used to giving it? They talk about Compass Pathways filing an application with the SEC for a NASDAQ listing, as well as already raising over $80 million towards funding clinical trials for psilocybin-based therapy for treatment-resistant depression, and the ways corporati